Company / Interest Expense per Share
PLUS THERAPEUTICS, INC. Interest Expense per Share History
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.35
FY2018
5-year range
$0.01 / $0.35
FY2014-FY2018
Trend
+2634.1%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share changed +2634% YoY in FY2018, a notable deviation from the 7-year average annual change of +462%.
Based on SEC 10-K filings.
0.35 in FY2018 with a 5-year CAGR of +53.0%.
Increased from $0.26 to $0.35 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +118.0%
- 5-Year CAGR
- +53.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2018, interest expense per share increased 2634.1% year-over-year.
- Lowest interest expense per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2018 | $0.35 | +2634.1% |
| FY2017 | $0.01 | -95.0% |
| FY2016 | $0.26 | +660.2% |
| FY2015 | $0.03 | -28.0% |
| FY2014 | $0.05 | +12.4% |
| FY2013 | $0.04 | +16.5% |
| FY2012 | $0.04 | +32.0% |
| FY2011 | $0.03 | - |
As of FY2018 · SEC 10-K · Updated Jun 28, 2026